Literature DB >> 25162152

Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.

Motoki Natsuizaka1, Hirofumi Chiba, Koji Kuronuma, Mitsuo Otsuka, Kazumi Kudo, Mitsuru Mori, Masashi Bando, Yukihiko Sugiyama, Hiroki Takahashi.   

Abstract

RATIONALE: Idiopathic pulmonary fibrosis (IPF) has an unknown etiology and poor prognosis. Several large-scale epidemiologic studies have been conducted predominantly in Western countries. There are few studies reported from Asian countries. It remains unclear whether ethnic difference exists in IPF. It is important to determine the current IPF status in Asian populations and compare it with that of Western populations.
OBJECTIVES: To provide the epidemiologic status of IPF in Japan and to investigate ethnic differences.
METHODS: We selected Hokkaido prefecture (population, 5.6 million) as the epidemiologic cohort of IPF among Japanese. On the basis of the clinical records of 553 patients with IPF who were accepted based on the application of the Certificate of Medical Benefit between 2003 and 2007, we conducted a retrospective epidemiologic and prognostic analysis.
MEASUREMENTS AND MAIN RESULTS: The prevalence and cumulative incidence of IPF was 10.0 and 2.23 per 100,000 population, respectively, with 72.7% predominance of males and an increase in frequency with age. The median survival time was 35 months, and the most common (40%) cause of death was acute exacerbation. The most important factor influencing IPF prognosis was the percent vital capacity.
CONCLUSIONS: The status of IPF in the Japanese population was clarified for the first time through our study. Our results showed that in men, the incidence of death caused by acute exacerbation was higher and that caused by cardiovascular disease was lower in Japan than in Western countries. These results may suggest ethnic differences in IPF.

Entities:  

Keywords:  IPF; Japanese; epidemiologic survey; ethnic differences

Mesh:

Year:  2014        PMID: 25162152     DOI: 10.1164/rccm.201403-0566OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  110 in total

Review 1.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 2.  Idiopathic pulmonary fibrosis in East Asian.

Authors:  Changbo Sun; Yanbin Sun; Hui Shen; Chunlu Yang; Shun Xu
Journal:  Intractable Rare Dis Res       Date:  2017-05

3.  Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis.

Authors:  Haiyan Min; Shanshan Fan; Shiyu Song; Yi Zhuang; Hui Li; Yongzheng Wu; Hourong Cai; Long Yi; Jinghong Dai; Qian Gao
Journal:  Diagn Pathol       Date:  2016-11-23       Impact factor: 2.644

4.  Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.

Authors:  Aya Fukuizumi; Yuji Minegishi; Miwako Omori; Kenichiro Atsumi; Natsuki Takano; Kakeru Hisakane; Satoshi Takahashi; Kenichi Kobayashi; Teppei Sugano; Susumu Takeuchi; Rintaro Noro; Masahiro Seike; Kaoru Kubota; Arata Azuma; Akihiko Gemma
Journal:  Int J Clin Oncol       Date:  2019-07-27       Impact factor: 3.402

5.  Immunogenicity of pneumococcal vaccines in comorbid autoimmune and chronic respiratory diseases.

Authors:  Koji Kuronuma; Hiroki Takahashi
Journal:  Hum Vaccin Immunother       Date:  2019-01-30       Impact factor: 3.452

6.  Peroxidase Sensitive Amplifiable Probe for Molecular Magnetic Resonance Imaging of Pulmonary Inflammation.

Authors:  Aurora Rodríguez-Rodríguez; Sergey Shuvaev; Nicholas Rotile; Chloe M Jones; Clemens K Probst; Diego Dos Santos Ferreira; Katherine Graham-O Regan; Eszter Boros; Rachel S Knipe; Jason W Griffith; Andrew M Tager; Alexei Bogdanov; Peter Caravan
Journal:  ACS Sens       Date:  2019-08-22       Impact factor: 7.711

7.  Accumulation of periostin in acute exacerbation of familial idiopathic pulmonary fibrosis.

Authors:  Keisuke Murata; Yasuhiko Koga; Norimitsu Kasahara; Yoshimasa Hachisu; Satoshi Nunomura; Nozomi Nakajima; Hideaki Yokoo; Kyoichi Kaira; Toshitaka Maeno; Kunio Dobashi; Kenji Izuhara; Takeshi Hisada
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

8.  Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.

Authors:  Sergio Harari; Michele Davì; Alice Biffi; Antonella Caminati; Alessandra Ghirardini; Valeria Lovato; Claudio Cricelli; Francesco Lapi
Journal:  Intern Emerg Med       Date:  2019-09-20       Impact factor: 3.397

9.  Increased expression of transient receptor potential channels and neurogenic factors associates with cough severity in a guinea pig model.

Authors:  Mengyue Guan; Sun Ying; Yuguang Wang
Journal:  BMC Pulm Med       Date:  2021-06-02       Impact factor: 3.317

10.  Clinical importance of Bcl-2-like 11 deletion polymorphism in idiopathic pulmonary fibrosis.

Authors:  Kazutoshi Isobe; Takuma Issiki; Susumu Sakamoto; Go Sano; Yujiro Takai; Naobumi Tochigi; Sakae Homma
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.